| 英文别名： |
Pazopanib;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylBenzenesulfonamide;Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-m...;Pazopanib (GW-786034, Armala®, Votrient®);Pazopanib(GW786034); GW 786034;GW-786034;GW786034;7RN5DR86CK;GW 78603;DSSTox_RID_82929;DSSTox_CID_28659;DSSTox_GSID_48733;5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide;5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide;5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesul;EX-A1241;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide;PAZOPANIB [VANDF];5-(3-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)phenylamino)-2-methylbenzenesulfonamide;HY-10208;5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide;GW7 86034;HMS3244C22;Pazopanib [INN];Z1541638525;Q-101400;GW 786034B;PAZOPANIB [EMA EPAR];NSC800839;5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide;AB01273967-02;AM20090659;MFCD11616589;CS-0269;DTXSID8048733;SW218082-3;BCPP000129;DTXCID1028659;indazolylpyrimidine 13;s3012;UNII-7RN5DR86CK;Pazopanib [INN:BAN];AS-11066;PAZOPANIB [MI];Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-;BCP01839;790713-33-6;Kinome_3790;GW780604;BCP9001053;SCHEMBL588608;JMC514632 Compound 13;CAS-444731-52-6;HSDB 8210;HMS3745G05;PAZOPANIB [WHO-DD];444731-52-6;5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide;Tox21_113174;AB01273967_05;5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;GW-780604;5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide;CUIHSIWYWATEQL-UHFFFAOYSA-N;NSC-800839;BD164238;NCGC00188865-02;BDBM26474;FT-0684794;A19406;AKOS005145819;cid_10113978;GTPL5698;Q7157043;AB01273967_06;DB06589;NCGC00188865-01;FT-0659928;P-6706;NSC752782;NSC-752782;NCGC00188865-10;BRD-K74514084-003-02-7;CHEBI:71219;NSC 752782;NCGC00188865-03;Pazopanib- Bio-X;HMS3244C21;CCG-265010;5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide;5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide;Tox21_113174_1;Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-;AC-8522;HMS3244D21;5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide;pazopanibum;Pazopanib (free base);AB01273967-01;5-[... |
| 详细描述： |
|
Pazopanib is a potent and selective multi-targeted tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (Flk-1), platelet-derived growth factor receptor (PDGFR) and c-kit, which are key proteins responsible for tumor growth and angiogenesis.A potent and selective inhibitor of Flk-1, PDGFR and c-kit
Pazopanib is a potent and selective multi-targeted tyrosine kinase inhibitor that targets vascular endothelial growth factor receptor (Flk-1), platelet-derived growth factor receptor (PDGFR) and c-kit, which are key proteins responsible for tumor growth and angiogenesis.
A potent and selective inhibitor of Flk-1, PDGFR and c-kit
|
|
沪公网安备31011402010658号 
